Suppr超能文献

药物诱导骨钙素γ羧化作用降低:备用机制是什么?

Drug-induced Reduction of Gamma Carboxylation in Osteocalcin: What is the Fallback?

作者信息

Usman Norina, Qaseem Aisha, Jayaraj Joseph S, Fathima Nida, Janapala Rajesh Naidu

机构信息

Internal Medicine, Veterans Affairs Palo Alto Health Care System - Stanford University School of Medicine, Palo Alto, USA.

Internal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.

出版信息

Cureus. 2019 Aug 28;11(8):e5504. doi: 10.7759/cureus.5504.

Abstract

Osteoporosis is a medical condition in which bone becomes fragile and weak. In this condition, the quality and density of the bone are reduced. Vitamin K is vital for bone mineralization as it plays a vital role in the gamma-carboxylation of osteocalcin. Therefore, if there is a deficiency of vitamin K, it can lead to osteoporosis due to undercarboxylated osteocalcin. Warfarin is the most widely used anticoagulant in the elderly. In this article, we reviewed how Warfarin, an inhibitor of vitamin K, affects bone remodeling and leads to osteoporosis.

摘要

骨质疏松症是一种骨骼变得脆弱和易碎的医学状况。在这种情况下,骨骼的质量和密度会降低。维生素K对骨矿化至关重要,因为它在骨钙素的γ-羧化过程中起着关键作用。因此,如果维生素K缺乏,由于骨钙素羧化不足,可能会导致骨质疏松症。华法林是老年人中使用最广泛的抗凝剂。在本文中,我们综述了维生素K抑制剂华法林如何影响骨重塑并导致骨质疏松症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5edc/6816527/70a546c15914/cureus-0011-00000005504-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验